BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32175789)

  • 1. Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies.
    Ros-Martínez S; Navas-Carrillo D; Alonso-Romero JL; Orenes-Piñero E
    Crit Rev Clin Lab Sci; 2020 Nov; 57(7):432-443. PubMed ID: 32175789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
    Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
    Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
    Galon J; Mlecnik B; Bindea G; Angell HK; Berger A; Lagorce C; Lugli A; Zlobec I; Hartmann A; Bifulco C; Nagtegaal ID; Palmqvist R; Masucci GV; Botti G; Tatangelo F; Delrio P; Maio M; Laghi L; Grizzi F; Asslaber M; D'Arrigo C; Vidal-Vanaclocha F; Zavadova E; Chouchane L; Ohashi PS; Hafezi-Bakhtiari S; Wouters BG; Roehrl M; Nguyen L; Kawakami Y; Hazama S; Okuno K; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Wang Y; Kopetz S; Sinicrope FA; Scripcariu V; Ascierto PA; Marincola FM; Fox BA; Pagès F
    J Pathol; 2014 Jan; 232(2):199-209. PubMed ID: 24122236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
    Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscore and its introduction in clinical practice.
    Galon J; Lanzi A
    Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):152-161. PubMed ID: 32107902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Immunoscore as prognostic tool for hepatocellular carcinoma.
    Petrizzo A; Buonaguro L
    J Immunother Cancer; 2016; 4():71. PubMed ID: 27879973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer classification using the Immunoscore: a worldwide task force.
    Galon J; Pagès F; Marincola FM; Angell HK; Thurin M; Lugli A; Zlobec I; Berger A; Bifulco C; Botti G; Tatangelo F; Britten CM; Kreiter S; Chouchane L; Delrio P; Arndt H; Asslaber M; Maio M; Masucci GV; Mihm M; Vidal-Vanaclocha F; Allison JP; Gnjatic S; Hakansson L; Huber C; Singh-Jasuja H; Ottensmeier C; Zwierzina H; Laghi L; Grizzi F; Ohashi PS; Shaw PA; Clarke BA; Wouters BG; Kawakami Y; Hazama S; Okuno K; Wang E; O'Donnell-Tormey J; Lagorce C; Pawelec G; Nishimura MI; Hawkins R; Lapointe R; Lundqvist A; Khleif SN; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Palmqvist R; Nagtegaal ID; Wang Y; D'Arrigo C; Kopetz S; Sinicrope FA; Trinchieri G; Gajewski TF; Ascierto PA; Fox BA
    J Transl Med; 2012 Oct; 10():205. PubMed ID: 23034130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoscore and Its Predictive Value for Colorectal Cancer].
    Závadová E; Špaček J; Vočka M; Konopásek B; Fučíková T; Netíková I; Dundr P; Skálová H; Petruželka L
    Klin Onkol; 2015; 28 Suppl 4():4S82-5. PubMed ID: 26647895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
    Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
    Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune infiltration in human tumors: a prognostic factor that should not be ignored.
    Pagès F; Galon J; Dieu-Nosjean MC; Tartour E; Sautès-Fridman C; Fridman WH
    Oncogene; 2010 Feb; 29(8):1093-102. PubMed ID: 19946335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy.
    Li XD; Huang CW; Liu ZF; Jiang LJ; Chen JW; Xie D; Zhou FJ; Lu HM; Liu ZW
    Ann Surg Oncol; 2019 Nov; 26(12):4148-4156. PubMed ID: 31376036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
    Guo L; Wang C; Qiu X; Pu X; Chang P
    Front Immunol; 2020; 11():1052. PubMed ID: 32547556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
    Bruni D; Angell HK; Galon J
    Nat Rev Cancer; 2020 Nov; 20(11):662-680. PubMed ID: 32753728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes.
    Guo G; Wang Y; Zhou Y; Quan Q; Zhang Y; Wang H; Zhang B; Xia L
    J Immunother Cancer; 2019 Jul; 7(1):179. PubMed ID: 31300050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic quality of the Union Internationale Contre le Cancer/American Joint Committee on Cancer TNM classification, 7th edition, for cancer of the maxillary sinus.
    Kreppel M; Amir Manawi NN; Scheer M; Nickenig HJ; Rothamel D; Dreiseidler T; Drebber U; Zinser M; Zöller JE; Guntinas-Lichius O; Preuss SF
    Head Neck; 2015 Mar; 37(3):400-6. PubMed ID: 24431114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intratumoral immune microenvironment and survival: the immunoscore].
    Galon J; Bindea G; Mlecnik B; Angell H; Lagorce C; Todosi AM; Berger A; Pagès F
    Med Sci (Paris); 2014 Apr; 30(4):439-44. PubMed ID: 24801041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High immune cell score predicts improved survival in pancreatic cancer.
    Tahkola K; Mecklin JP; Wirta EV; Ahtiainen M; Helminen O; Böhm J; Kellokumpu I
    Virchows Arch; 2018 Apr; 472(4):653-665. PubMed ID: 29356891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
    Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
    Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer.
    Hülsen S; Lippolis E; Ferrazzi F; Otto W; Distel L; Fietkau R; Denzinger S; Breyer J; Burger M; Bertz S; Eckstein M; Ebner A; Hartmann A; Geppert CI
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.